| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage |
| 09/19/2000 | US6120989 Isolated human cytomegalovirus polypeptides and uses thereof |
| 09/19/2000 | US6120767 Genetic engineering |
| 09/19/2000 | CA2050601C Production in bacteria and yeast of hemoglobin and analogues thereof |
| 09/14/2000 | WO2000053790A1 Target cell-specific, multivalent proteins (mvp) |
| 09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
| 09/14/2000 | WO2000053631A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | WO2000053623A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | WO2000053223A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| 09/14/2000 | CA2478736A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478730A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478728A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367315A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | CA2366689A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/13/2000 | EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response |
| 09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
| 09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |
| 09/12/2000 | US6117680 Compositions and methods for regulation of transcription |
| 09/12/2000 | US6117653 Hepatitis B surface antigen vaccine |
| 09/12/2000 | US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease |
| 09/08/2000 | WO2000052184A1 Anti-neoplastic compositions and uses thereof |
| 09/08/2000 | WO1999064595A9 THERAPEUTIC AND DIAGNOSTIC DOMAIN 1 β2GPI POLYPEPTIDES AND METHODS OF USING SAME |
| 09/08/2000 | CA2362995A1 Anti-neoplastic compositions and uses thereof |
| 09/06/2000 | EP1032688A1 Single-chain bifunctional glycoprotein hormones |
| 09/06/2000 | EP1032678A1 Hormone-dependent forms of the adeno-associated virus, rep proteins, dna sequences coding for them, vectors containing them, and regulatory methods of their intracellular activity |
| 09/06/2000 | EP1032676A2 $i(CHLAMYDIA TRACHOMATIS) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032674A2 $i(CHLAMYDIA PNEUMONIAE) GENOMIC SEQUENCE AND POLYPEPTIDES, FRAGMENTS THEREOF AND USES THEREOF, IN PARTICULAR FOR THE DIAGNOSIS, PREVENTION AND TREATMENT OF INFECTION |
| 09/06/2000 | EP1032673A1 Improvements relating to protein accumulation |
| 09/06/2000 | EP1032672A1 Dna19355 polypeptide, a tumor necrosis factor homolog |
| 09/06/2000 | EP1032665A1 A human 2-19 protein homologue, z219c |
| 09/06/2000 | EP1032661A1 Apo-2DcR |
| 09/06/2000 | CN1056084C Immunotoxins directed against CD33 related surface antigens |
| 09/05/2000 | US6114598 Generation of xenogeneic antibodies |
| 09/05/2000 | US6114388 Monofunctional and/or polyfunctional polylysine conjuages |
| 09/05/2000 | US6114180 Human cardiac troponin |
| 09/05/2000 | US6114147 Immobilizing protein by modifying a fungus to produce a chimeric protein composed of a binding protein, a secretory signal peptide, and an anchoring portion; producing protein; transporting to cell wall; for separating target compounds |
| 09/05/2000 | US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
| 09/05/2000 | US6113911 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 09/05/2000 | US6113901 Immunopotentiating cd-3 antigen monoclonal antibodies |
| 08/31/2000 | WO2000050590A1 Mdm interacting protein and methods of use thereof |
| 08/31/2000 | WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
| 08/31/2000 | WO2000023472A3 Interferon-beta fusion proteins and uses |
| 08/31/2000 | WO2000018932A9 Receptor based antagonists and methods of making and using |
| 08/31/2000 | CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
| 08/31/2000 | CA2363106A1 Mdm interacting protein and methods of use thereof |
| 08/30/2000 | EP1030928A1 Development of viruses resistant to inactivation by the human complement system |
| 08/30/2000 | EP1030919A2 Cdk2 protein and cdk2 protein complexes |
| 08/30/2000 | EP1030867A1 Mammalian milk growth factor |
| 08/30/2000 | EP1030819A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/29/2000 | US6110706 Amino acid sequences; for increased immunogenicity |
| 08/29/2000 | CA2034487C Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
| 08/29/2000 | CA2015687C Human serum albomin fusion polypeptide |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/24/2000 | WO2000049416A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 08/24/2000 | WO2000049040A2 Antimicrobial/endotoxin neutralizing polypeptide |
| 08/24/2000 | WO2000049039A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048558A1 Modified calycins |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2368461A1 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | CA2362987A1 Receptor assay |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362284A1 Modified calycins |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029065A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
| 08/23/2000 | EP1029049A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 08/23/2000 | EP1029046A2 Wnt-1 inducible genes |
| 08/23/2000 | EP1028980A1 ASSAY EMPLOYING CadC FUSION PROTEINS |
| 08/23/2000 | EP1028979A1 Variable region fusion peptides that form effector complexes in the presence of antigen |
| 08/23/2000 | CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6106832 Treating x-linked hyper igm syndrome and combined variable immunodeficiency syndrome |
| 08/22/2000 | CA2056381C Cysteine thiol-protected peptides for use in immunoassays |
| 08/22/2000 | CA2031199C Antibacterial and antimalarial peptides |
| 08/17/2000 | WO2000047751A1 Intein-mediated protein ligation of expressed proteins |
| 08/17/2000 | WO2000047622A2 Peptides with anti-angiogenic activity |
| 08/17/2000 | WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
| 08/17/2000 | WO2000047610A2 Method for altering undesirable immune responses to polypeptides |
| 08/17/2000 | WO2000047220A1 Controlling protein levels in eucaryotic organisms |
| 08/17/2000 | CA2362560A1 Controlling protein levels in eucaryotic organisms |
| 08/17/2000 | CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |